...
首页> 外文期刊>Clinical and Translational Medicine >Lack of durable protection against cotton smoke-induced acute lung injury in sheep by nebulized single chain urokinase plasminogen activator or tissue plasminogen activator
【24h】

Lack of durable protection against cotton smoke-induced acute lung injury in sheep by nebulized single chain urokinase plasminogen activator or tissue plasminogen activator

机译:通过雾化单链尿激酶纤溶酶原激活剂或组织纤溶酶原激活剂缺乏耐用耐用耐用保护绵羊急性肺损伤

获取原文
           

摘要

Background Airway fibrin casts are clinically important complications of severe inhalational smoke-induced acute lung injury (ISIALI) for which reliable evidence-based therapy is lacking. Nebulized anticoagulants or a tissue plasminogen activator; tPA, has been advocated, but airway bleeding is a known and lethal potential complication. We posited that nebulized delivery of single chain urokinase plasminogen activator, scuPA, is well-tolerated and improves physiologic outcomes in ISIALI. To test this hypothesis, we nebulized scuPA or tPA and delivered these agents every 4?h to sheep with cotton smoke induced ISIALI that were ventilated by either adaptive pressure ventilation/controlled mandatory ventilation (APVcmv; Group 1, n?=?14) or synchronized controlled mandatory ventilation (SCMV)/limited suctioning; Group 2, n?=?32). Physiologic readouts of acute lung injury included arterial blood gas analyses, PaO~(2)/FiO~(2)ratios, peak and plateau airway pressures, lung resistance and static lung compliance. Lung injury was further assessed by histologic scoring. Biochemical analyses included determination of antigenic and enzymographic uPA and tPA levels, plasminogen activator and plasminogen activator inhibitor-1 activities and d -dimer in bronchoalveolar lavage (BAL). Plasma levels of uPA, tPA antigens, d -dimers and α-macroglobulin-uPA complex levels were also assessed. Results In Group 1, tPA at the 2?mg dose was ineffective, but at 4?mg tPA or scuPA, the PaO~(2)/FiO~(2)ratios, peak/plateau pressures improved during evolving injury (p?
机译:背景技术纤维蛋白铸件是严重吸入烟雾诱导的急性肺损伤(ISIALI)的临床重要的并发症,用于缺乏可靠的循证疗法。雾化的抗凝血剂或组织纤溶酶原激活剂; TPA已经提倡,但气道出血是一种已知的和致命的潜在并发症。我们假设雾化尿激酶纤溶酶原激活剂,SCUPA的雾化递送良好,具有良好的耐受性,并改善ISIALI的生理结果。为了测试这一假设,我们雾化了SCUPA或TPA,每4次用棉花诱导的ISIALI养羊皮,并通过自适应压力通风/控制的强制通风(APVCMV; 1,N?= 14组)通风,将这些药剂送到绵羊。同步控制的强制通风(SCMV)/有限吸引;第2组,n?=?32)。急性肺损伤的生理读数包括动脉血液分析,Pao〜(2)/ fio〜(2)比率,峰值和高原气道压力,肺抗性和静态肺顺应性。通过组织学评分进一步评估肺损伤。生物化学分析包括抗原和酶促uPA和TPA水平,纤溶酶原激活剂和纤溶酶原激活物抑制剂-1活性和Ddimer在支气管肺泡灌洗(BAL)中的测定。还评估了血浆uPA,TPA抗原,D-dimers和α-宏观球蛋白 - upa复合水平。结果在第1组中,2?Mg​​剂量的TPA是无效的,但在4?Mg TPA或SCUPA,Pao〜(2)/ fiO〜(2)比率,峰/平台压力在不断变化损伤期间改善(P? 0.01)在48Ω腔下没有显着差异。为了改善干预措施的递送,在第2组中重复实验,吸入/ SCMV有限,通常增加(BAL)的PAS。在第2组中,TPA无效,但SCUPA(4或8?MG)改善了生理结果(P?<β01)和高原压力在48Ω℃下仍然更低。气道出血发生在8?Mg TPA。 BAL纤溶酶原激活剂(PA)水平与48μm的生理结果正相关。结论生理结果在绵羊中改善,其中发生了更好的递送PAS。在没有与TPA相关的气道出血的情况下实现了雾化SCUPA的益处,但是在48℃下瞬态并且主要被抛弃,部分归因于ISIALI的进展和严重程度。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号